Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for metabolism, inborn errors

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Feb 2025: Trial registered, NCT06839456
  2. 21 Mar 2025: Trial started, NCT06839456

The trials

NCT06839456: Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

State
Under way
Phase
Phase 1 and Phase 2
People
100 planned
Started
21 Mar 2025
Primary completion
Mar 2031
Arms
Phase 1:TCRab/CD19 depleted PSCT with CD45RA depleted addback using mismatched related donors (MMRD)
Results
None posted
  1. 21 Feb 2025: Trial registered
  2. 21 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.